iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Shares Up 0.8% – Still a Buy?

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) rose 0.8% during trading on Wednesday . The company traded as high as $31.43 and last traded at $31.30. Approximately 12,858 shares traded hands during mid-day trading, an increase of 138% from the average daily volume of 5,402 shares. The stock had previously closed at $31.06.

iShares LifePath Target Date 2045 ETF Price Performance

The company has a market capitalization of $24.25 million, a price-to-earnings ratio of 21.45 and a beta of 0.90. The business’s 50 day simple moving average is $31.58 and its 200 day simple moving average is $31.61.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares LifePath Target Date 2045 ETF stock. Heck Capital Advisors LLC purchased a new position in shares of iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 869 shares of the company’s stock, valued at approximately $27,000. Heck Capital Advisors LLC owned 0.27% of iShares LifePath Target Date 2045 ETF as of its most recent SEC filing.

iShares LifePath Target Date 2045 ETF Company Profile

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.